Roche - activities

Covid: casirivimab/imdevimab cocktail, Regeneron’s promising treatment against the virus

This Monday April 12, Roche and Regeneron laboratories have issued results from phase 3 of their clinical trial for a treatment against Covid, a cocktail of casirivimab and imdevimab able to cut the risk of transmitting the virus within populations.